Plasma samples collected in 1990 from free-ranging desert tortoises (Gopherus agassizii) with and without clinical signs of upper respiratory tract disease (URTD) from Las Vegas Valley, Clark County, Nevada (USA), were tested by enzyme-linked immunosorbent assay (ELISA) for antibodies to Mycoplasma agassizii, a causative agent of URTD. The relationship between clinical signs and ELISA test results was evaluated. Of the 144 tortoises tested, 45 (31%) had clinical signs while 72 (50%) were seropositive. Presence of clinical signs of URTD was positively related to positive ELISA results (P < 0.0001) regardless of sex or age of the animal. Eighty-four percent of animals with clinical signs tested seropositive. Mucous nasal discharge, the most severe and obvious of the clinical signs, was highly predictive for exposure to M. agassizii based on the ELISA. Ninety-three percent of tortoises with mucous nasal discharge tested seropositive. Serologic testing for M. agassizii antibodies supported clinical signs as useful indicators of URTD, but it also detected potential subclinical infection in 34 (34%) of 99 animals without clinical signs.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 33 • No. 2